Previous studies have revealed that the SARS-CoV-2 uses the same cell entry receptor, angiotensin-converting enzyme 2 (ACE2), as SARS-CoV, to invade the human host and cause a primary pneumonia (22). The gene discussed is ACE2; the disease is pneumonia.